Flare Therapeutics is focused on developing small molecule medicines that target transcription factors to treat diseases, particularly in precision oncology. Their pipeline includes programs for advanced urothelial cancer and prostate cancer, leveraging a unique approach to drug discovery.

Flare Therapeutics is focused on developing small molecule medicines that target transcription factors to treat diseases, particularly in precision oncology. Their pipeline includes programs for advanced urothelial cancer and prostate cancer, leveraging a unique approach to drug discovery.